The sentencing of Matthew Perry’s assistant, Kenneth Iwamasa, for administering the ketamine that killed the ‘Friends’ star has sent ripples through Hollywood and across the Atlantic. Iwamasa received five years’ probation after admitting to injecting Perry with the drug on the day of his death, a plea deal that has left many in the UK’s addiction sector questioning whether justice has been diluted by celebrity.
But this is not just a story about one man’s complicity. It is a story about a system that, on both sides of the pond, often handles addiction with a mixture of moral panic and legal inconsistency. In the wake of Perry’s death, UK charities have renewed calls for reform: they want decriminalisation of possession for personal use, better access to treatment, and a shift away from the punitive model that sees users, not dealers, as the primary targets.
Matthew Perry was open about his decades-long battle with addiction. He wrote about it, spoke about it, and founded a sober living facility for men. His death, at 54, was a tragedy that many hoped would spark a genuine conversation about the failures of the war on drugs. Instead, the focus has been on the assistant, the doctor, and the supply chain.
On the streets of London, the response is mixed. In Soho, outside a clinic that offers both private and NHS addiction services, a woman named Sarah tells me: “It’s a shame. He had everything and still couldn’t get the right help. They treat addiction like a crime rather than a health issue.” Her sentiment echoes the data: UK deaths from drug misuse hit record highs in 2023, and the number of people in treatment is still below pre-pandemic levels.
The case has also highlighted the glaring disparity in how addiction is perceived based on wealth and status. Perry could afford top-tier rehab and a personal assistant who would inject him. For many, the line between enabler and carer blurs. ‘Iwamasa was just doing what he was asked, but he also knew it was wrong,’ says a spokesperson for Addiction UK. ‘We need to look at the whole chain of enabling, not just the last link.’
And yet, the real reform lies beyond sentences and strategies. It lies in the cultural shift that separates addiction from morality. Perry’s death has already changed the conversation: how many times have we heard that ketamine, when used under medical supervision, can be a miracle drug for depression? The answer is plenty. The discrepancy between therapeutic and recreational use is one that the system has not yet reconciled.
For now, the assistant is sentenced, but the assistants of the world – those who enable because they are paid, or because they love – remain a grey area. Meanwhile, UK charities warn that without policy change, the cycle will continue. Matthew Perry is no longer here to advocate, but his death has become a catalyst for a debate that, perhaps, he would have wanted. One that asks not just about one overdose, but about the entire ecosystem of pain, profit, and permissiveness.
As one charity worker put it: “We can’t arrest our way out of an addiction crisis. We need to treat our way out. And that starts with seeing the person, not the case.”
